Methylene blue is a potent monoamine oxidase inhibitor (correspondence) (2008)

Peer-Reviewed Study · Gillman PK · May 2008

Gillman PK, 2008-05: Published correspondence arguing, from the pharmacology, that methylene blue is a potent monoamine oxidase inhibitor and that this explains serotonin toxicity with serotonergic drugs. It is a letter, not a study.

Gillman PK, 2008-05: Published correspondence arguing, from the pharmacology, that methylene blue is a potent monoamine oxidase inhibitor and that this explains serotonin toxicity with serotonergic drugs. It is a letter, not a study. Study type: correspondence/letter (no abstract). Country: Australia (author). Content: the title itself is the claim – 'Methylene blue is a potent monoamine oxidase inhibitor'. No abstract or full text could be retrieved through the automated route, so no excerpt is recorded and confidence is LOW. The same pharmacological point is documented with data in MTF-36 and in the FDA label (MTF-34). Study type: other.